On March 31, Meshalkin National Medical Research Centre held a masterclass on the Use of High Technologies in the Treatment of Patients at High Risk of Peripheral Arterial Restenosis, which brought together many experts from the leading clinics in the field of X-ray endovascular and vascular surgery.
The event focused on one of the most topical issues in endovascular treatment of peripheral arteries — lesion restenosis. Almaz Vanyurkin, a researcher at the Research Department of Vascular and Interventional Surgery of Almazov Centre, gave a presentation entitled “Almazov Centre’s experience in the use of drug-eluting technologies and atherectomy” dedicated to the experience of vascular surgeons in the use of drug stents and balloons as well as atherectomy devices for the treatment of peripheral arterial occlusions.
 |
 |
The use of paclitaxel-coated balloons and eluting stents is an advanced, effective and safe method of treating arterial stenosis in the lower limbs. The treatment is based on balloon angioplasty of the arteries with subsequent accumulation of paclitaxel in the tissues of the vessel wall, which prevents the development of restenosis in the long term. Until recently, in the case of extensive atherosclerotic plaques, specialists could only perform open procedures that injure the vessel wall – loop endarterectomy. Specialists at Almazov Centre and all over the world have long since abandoned such a procedure, as the technologies of endovascular atherectomy have become available – a technique that uses a special catheter to remove atherosclerotic masses through a puncture in the femoral artery.
The combination of atherectomy and drug-eluting technologies is an undeniable advantage of endovascular treatment of peripheral arterial disease. The use of the new technology helps to reduce the length of hospital stay and rehabilitation compared to open surgery, and also has better long-term treatment outcomes than standard balloon angioplasty for lower extremity arterial occlusive disease.
Almazov Centre is a leading medical centre for endovascular and hybrid treatment of peripheral arterial disease. The accumulated experience allows the Centre's specialists to share their achievements with colleagues from different parts of the country and make them available to the scientific community.